Dual PI3K/mTOR Inhibition in Colorectal Cancers with APC and PIK3CA Mutations.
about
Timp1 Promotes Cell Survival by Activating the PDK1 Signaling Pathway in Melanoma.Anticancer potential of sanguinarine for various human malignancies.Autophagy inhibition sensitizes LY3023414-induced anti-glioma cell activity in vitro and in vivo.SAV1 represses the development of human colorectal cancer by regulating the Akt-mTOR pathway in a YAP-dependent manner.
P2860
Dual PI3K/mTOR Inhibition in Colorectal Cancers with APC and PIK3CA Mutations.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Dual PI3K/mTOR Inhibition in Colorectal Cancers with APC and PIK3CA Mutations.
@en
Dual PI3K/mTOR Inhibition in Colorectal Cancers with APC and PIK3CA Mutations.
@nl
type
label
Dual PI3K/mTOR Inhibition in Colorectal Cancers with APC and PIK3CA Mutations.
@en
Dual PI3K/mTOR Inhibition in Colorectal Cancers with APC and PIK3CA Mutations.
@nl
prefLabel
Dual PI3K/mTOR Inhibition in Colorectal Cancers with APC and PIK3CA Mutations.
@en
Dual PI3K/mTOR Inhibition in Colorectal Cancers with APC and PIK3CA Mutations.
@nl
P2093
P2860
P1476
Dual PI3K/mTOR Inhibition in Colorectal Cancers with APC and PIK3CA Mutations.
@en
P2093
Alex E Yueh
Cheri A Pasch
Dana R Van De Hey
Demetra P Korkos
Dustin A Deming
Kristina A Matkowskyj
Linda Clipson
Michael A Newton
Molly E Maher
Susan N Payne
P2860
P304
P356
10.1158/1541-7786.MCR-16-0256
P577
2017-02-09T00:00:00Z